IFNG and cancer: A 33 diverse cancer immune subtype classification has described the immune landscape of BCa according to the immune expression characteristics of four representative signatures: C1 (wound healing), C2 (IFN-γ dominant), C3 (inflammatory), and C4 (lymphocyte depleted) (Thorsson et al., 2018).